Atlas Trials

A Study to Assess the Safety and Tolerability of Single and Multiple Doses of AZD4831 in Healthy Male Subjects

Clinical trial NCT02712372 · TERMINATED

Trial details

NCT number
NCT02712372
Sponsor
AstraZeneca
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Cardiovascular Disease
Start date
2016-06-01
Primary completion
2016-10-01
Enrollment
104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.